December 2011

Akorn AKORN Acquires Three Hospital-Based Branded Injectables

LAKE FOREST, IL— December 22, 2011 -- Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today announced that its wholly-owned subsidiary, Oak Pharmaceuticals, has acquired three off patent, branded, hospital-based injectables from the US subsidiary of H. Lundbeck A/S. According to the agreement, Akorn will make an upfront payment of $45 million and a subsequent milestone payment of $15million in cash after 3 years.

Special ISTP Business Insights Program: Life Science in India - Join Michael Rosen and a panel of Experts

January 25, 2012 at 4 – 6 pm at The Illinois Science + Technology Park


Astellas Signs United Nations Global Compact

Tokyo, Japan, November 11, 2011 - Astellas Pharma Inc. (Tokyo:4503,“Astellas”) announced today that it is signing the United Nations Global Compact1, which will further reinforce the company’s commitment to corporate social responsibility (CSR) and ethical business practices around the world.